Immunohistochemistry for PRAME in Dermatopathology

Area of Science:

• Oncology
• Dermatopathology
• Immunohistochemistry

Background:

• Preferentially expressed antigen in melanoma (PRAME) is a tumor antigen found in most melanomas.
• PRAME expression is also detected in other cancers, but at variable levels.
• Immunohistochemistry (IHC) allows PRAME detection in formalin-fixed paraffin-embedded tissues.

Purpose of the Study:

• To evaluate the utility of PRAME IHC as an ancillary diagnostic tool for melanocytic lesions.
• To compare PRAME expression patterns in melanoma versus nevi.
• To identify potential pitfalls and limitations of PRAME IHC in dermatopathology.

Main Methods:

• Utilized immunohistochemistry (IHC) with monoclonal antibodies to detect PRAME.
• Analyzed PRAME nuclear immunoreactivity patterns in in situ and invasive melanoma.
• Compared PRAME staining in melanomas, nevi, and other challenging melanocytic tumors.

Main Results:

• Melanomas frequently exhibit diffuse nuclear PRAME immunoreactivity.
• Nevi typically show infrequent and nondiffuse PRAME staining.
• Metastatic melanomas are generally PRAME-positive, while nodal nevi are not.

Conclusions:

• PRAME IHC is a valuable ancillary tool for evaluating melanocytic lesions.
• PRAME IHC results should be interpreted alongside other diagnostic tests, as they are not interchangeable.
• Understanding PRAME IHC's sensitivity, specificity, and potential pitfalls is crucial for accurate diagnosis.